Alessio Amatu Selected Research

disitamab vedotin

3/2022

The evolving panorama of HER2-targeted treatments in metastatic urothelial cancer: A systematic review and future perspectives.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alessio Amatu Research Topics

Disease

41	Colorectal Neoplasms (Colorectal Cancer) 02/2024 - 11/2008
35	Neoplasms (Cancer) 02/2024 - 03/2008
6	Disease Progression 01/2021 - 07/2015
5	Neoplasm Metastasis (Metastasis) 01/2021 - 11/2008
3	Circulating Neoplastic Cells 05/2021 - 01/2021
3	Cholangiocarcinoma 02/2016 - 09/2008
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 01/2017
2	Rectal Neoplasms (Rectal Cancer) 01/2020 - 09/2019
2	Pain (Aches) 04/2016 - 03/2008
1	Neuroinflammatory Diseases 12/2022
1	Turcot syndrome 01/2022
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2017
1	Central Nervous System Diseases (CNS Diseases) 01/2017
1	Mammary Analogue Secretory Carcinoma 01/2017
1	Melanoma (Melanoma, Malignant) 01/2017
1	Exanthema (Rash) 06/2016
1	Fatigue 06/2016
1	Neuralgia (Stump Neuralgia) 04/2016
1	Cancer Pain 04/2016
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 02/2016
1	Carcinogenesis 03/2014
1	Breast Neoplasms (Breast Cancer) 02/2012
1	Thrombocytopenia (Thrombopenia) 02/2011
1	Chronic Hepatitis C 01/2009
1	Infections 01/2009
1	Autoimmune Diseases (Autoimmune Disease) 01/2009
1	Sclerosis 01/2009
1	Liver Diseases (Liver Disease) 01/2009
1	Mesothelioma 03/2008
1	Malignant Mesothelioma 03/2008

Drug/Important Bio-Agent (IBA)

8	Circulating Tumor DNAIBA 02/2024 - 07/2015
7	Biomarkers (Surrogate Marker)IBA 02/2024 - 03/2014
7	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2022 - 09/2008
7	Panitumumab (Vectibix)FDA Link 01/2022 - 02/2014
6	Proteins (Proteins, Gene)FDA Link 02/2024 - 01/2016
6	Cetuximab (Erbitux)FDA Link 12/2023 - 02/2014
6	Monoclonal AntibodiesIBA 01/2023 - 06/2013
5	ErbB Receptors (EGF Receptor)IBA 01/2022 - 06/2013
4	AntibodiesIBA 12/2022 - 02/2014
4	Calcibiotic Root Canal SealerIBA 01/2016 - 02/2014
3	Trastuzumab (Herceptin)FDA Link 12/2020 - 06/2016
3	Lapatinib (GW572016)FDA Link 12/2020 - 06/2016
3	regorafenibIBA 01/2019 - 03/2014
3	entrectinibIBA 01/2017 - 12/2015
3	Phosphotransferases (Kinase)IBA 01/2017 - 06/2013
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2021
2	Temozolomide (Temodar)FDA LinkGeneric 01/2022 - 01/2017
2	VaccinesIBA 01/2022 - 01/2022
2	Cell-Free Nucleic AcidsIBA 01/2021 - 11/2018
2	pertuzumabIBA 12/2020 - 01/2020
2	Dacarbazine (DIC)FDA LinkGeneric 01/2017 - 04/2013
1	Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA 02/2024
1	AntigensIBA 12/2022
1	disitamab vedotinIBA 03/2022
1	trastuzumab duocarmazineIBA 03/2022
1	pembrolizumabIBA 01/2022
1	mRNA VaccinesIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Doxycycline (Periostat)FDA LinkGeneric 07/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	encorafenibIBA 01/2021
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 01/2021
1	Apoptosis Regulatory ProteinsIBA 01/2021
1	Granzymes (Granzyme)IBA 01/2021
1	Fluorouracil (Carac)FDA LinkGeneric 01/2020
1	Ado-Trastuzumab EmtansineIBA 01/2020
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2020
1	olaparibIBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	MEHD7945AIBA 01/2018
1	Tyrosine (L-Tyrosine)FDA Link 01/2017
1	Alkylating AgentsIBA 01/2017
1	Aligeron (AS 2)IBA 01/2017
1	Codon (Codons)IBA 06/2016
1	BilirubinIBA 06/2016
1	Gemcitabine FDA Link 02/2016
1	TropomyosinIBA 01/2016
1	tyrosine receptor (receptor, tyrosine)IBA 01/2016
1	Anaplastic Lymphoma KinaseIBA 12/2015
1	Angiopoietin-1IBA 03/2014
1	Protein Kinases (Protein Kinase)IBA 03/2014
1	Growth Factor ReceptorsIBA 03/2014
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2014
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 07/2013
1	DNA Repair EnzymesIBA 04/2013
1	Vinorelbine (Navelbine)FDA LinkGeneric 02/2012
1	Capecitabine (Xeloda)FDA Link 02/2012
1	Ribavirin (Virazole)FDA LinkGeneric 01/2009
1	InterferonsIBA 01/2009
1	Antiviral Agents (Antivirals)IBA 01/2009
1	Glycoproteins (Glycoprotein)IBA 03/2008

Therapy/Procedure

18	Therapeutics 01/2022 - 01/2009
4	Retreatment 11/2023 - 02/2019
4	Drug Therapy (Chemotherapy) 07/2021 - 11/2009
4	Microspheres (Microsphere) 02/2011 - 09/2008
3	Immunotherapy 01/2022 - 02/2019
1	Precision Medicine 01/2021
1	Radiotherapy 04/2016
1	Aftercare (After-Treatment) 04/2016
1	Electrodes (Electrode) 04/2008